Strategic Advice and Regulatory Analysis BlueReg experienced consultants can provide insight into all regulatory requirements for France:
- Drug Registration
- Early Access Programmes
- Post Marketing Authorisation Application (MAA) activities
- Promotional material review
- Quality systems and audits
- Interactions with healthcare professionals includingcompliance with the French laws (DMOS, Transparence de liens, Charte de l’information promotionnelle)
- Pharmacovigilance
- Pricing and reimbursement
Our experts
Our team can also support you through the entire application process from development, to registration and post-approval management
Associated News
The French system for preventing and managing shortages
The French regulation on the prevention and management of stock shortages of medicinal products is...